期刊文献+

儿童传染性单核细胞增多症患者GST基因遗传多态性的研究 被引量:3

Genetic polymorphism of glutathione s-transferase associated with childhood infectious mononucleosis
下载PDF
导出
摘要 目的探讨谷胱甘肽S-转移酶T1(GSTT1)和M1(GSTM1)基因多态性与儿童传染性单核细胞增多症(IM)发病风险的关系。方法采用病例-对照研究方法对52例IM患儿和60名健康儿童进行多重PCR技术检测GSTT1和GSTM1基因多态性,分析不同基因型与儿童IM发病的关系。结果IM组和对照组GSTT1纯合缺失基因型[GSTT1(-/-)]的分布频率分别为59.62%和43.33%,组间比较差异有显著性(χ2=7.231,P<0.05);携带GSTT1(-/-)基因型儿童发生IM的风险是携带GSTT1非纯合缺失基因型[GSTT1(+/+)或(+/-)]儿童的1.931倍[比值比(OR)=1.931,95%可信区间(CI):1.038~2.894]。GSTM1纯合缺失基因型[GSTM1(-/-)]的分布频率在IM组和对照组间差异无显著性(P>0.05)。基因型联合分析显示:携带GSTT1(-/-)与GSTM1(-/-)联合基因型的儿童,其IM的发病风险显著增加(OR=2.691,95%CI:0.902~6.127)。结论GSTT1纯合缺失基因型可能是儿童IM发生的重要危险内因之一。 [Objective] To investigate the association of glutathione S-transferase T1 (GSTrl) and glutathione Stransferase M1 (GSTM1) gene polymorphism with childhood infectious mononucleosis (IM). [Methods] The casecontrol study was conducted involving 52 childhood IM patients and 60 controls. The genetic polymorphisms of GSTI1 and GSTM1 were detected with multiplex polymerase chain reaction (PCR). The distribution difference of the genotypes between them was analyzed. [Results] The frequencies of GSTT1 null genotype was 59.62%, 43.33% in childhood IM and controls (Х^2=7.231, P〈0.05), respectively. There were 1.931 times of risks with occurrence IM for childhood individuals who carrying GSTrl null genotype than those carrying GSTT1 non-null genotype (OR=1.931, 95%GI: 1.038-2.894). There was no significant difference in the frequencies of GSTM1 null genotype in childhood IM and controls. Childhood individuals carrying both GSTT1 and GSTM1 null genotype were at high risks of occurrence IM (OR=2.691, 95%CI: 0.902-6.127). [Conclusion] The results of this study suggest that GSTT1 null genotype plays an important role in the occurrence of childhood IM.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第2期227-230,共4页 China Journal of Modern Medicine
基金 深圳市科技计划项目(医药卫生类)(No:200701019)
关键词 儿童传染性单核细胞增多症 GSTTI GSTM1 基因多态性 childhood infectious mononucleosis GSTT1 GSTM1 genetic polymorphism
  • 相关文献

参考文献11

  • 1KLEIN E, KIS LL, KLEIN G. Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions[R1. Oncogene, 2007, 26(9): 1297-1305.
  • 2AUWAERTER PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control[R]. Expert Rev Anti Infect Ther, 2006, 4(6): 1039-1049.
  • 3HATTA K, MORIMOTO A, ISHII E, et al. Association of trans-forming growth factor-betal gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases [J]. Haematologica, 2007, 92(11): 1470-1474.
  • 4MCAULAY KA, HIGGINS CD, MACSWEEN KF, et al. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection[J]. J Clin Invest, 2007, 117(10): 3042-3048.
  • 5AYADI W, FEKI L, KHABIR A, et al. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients[J]. Virus Genes, 2007, 34(2): 137-145.
  • 6梁冰,张爱华,奚绪光,黄晓欣.谷胱甘肽硫转移酶M1和T1基因多态性与燃煤型砷中毒发病的关系[J].中国地方病学杂志,2007,26(1):6-8. 被引量:13
  • 7REZK SA, WEISS LM. Epstein-Ban: virus-associated lymphopro- liferative disorders[R]. Hum Pathol, 2007, 38(9): 1293-1304.
  • 8MCILWAIN CC, TOWNSEND DM, TEW KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy [R]. Oncogene, 2006, 25(11): 1639-1648.
  • 9COLES BF, KADLUBAR FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease[R]. Methods Enzymol, 2005, 401: 9-42.
  • 10YE Z, SONG H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTTI) and the risk of acute leukaemia: a systematic review and meta-analysis[R]. Eur J Cancer, 2005, 41(7): 980-989.

二级参考文献20

  • 1陆凤娟,吴玉霞,高怡瑾,陈超,金泰廙,金锡鹏,夏昭林.GST基因多态性与儿童白血病易感性的关系[J].环境与职业医学,2004,21(4):258-260. 被引量:7
  • 2辛华雯,王润帮,杜光祖,林鲁杰.十种常用抗癌药体外敏感性与临床疗效相关性研究[J].中国医院药学杂志,1994,14(12):548-550. 被引量:29
  • 3赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 4孙殿军,高彦辉,于光前.中国“十一五”地方性砷中毒主要防治与研究任务的探析[J].中国地方病学杂志,2006,25(1):3-5. 被引量:39
  • 5VOLM M, MATTERN J, SAMSEL B. Overexpression of P-glycoprotein and gultathion S-transrerase-л in resistant non-small cell lung carcionomas of smokers[J]. Br J Cancer, 1991, 6(4): 700.
  • 6ABE S, KUBOTA T, MATSUZAKI SW, et al. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage Ⅲ non-scirrhous and scirrhous gastric cancers[J]. Anticancer Res, 1999, 19(5C): 4581-4586.
  • 7CARMICHAEL J, MITCHE II JB,DEGRAFF G. Chemosen sitivity testing of human lung cancer cell lines using the MTT assay[J]. Br J Cancer, 1998, 57(6): 540.
  • 8JAIN V, DAS SN, LUTHRA K, et al. Differential expression of multidrug resistance gene product, P-glycoprotein, in normanal,dysplastic and malignant oral mucosa in India[J]. Int J Cancer,1997, 74: 128-133.
  • 9GERMANN UA. P-glycoprotein:a mediator of multidrug resistance in tumor cells[J]. Eur J Cancer, 1996, 32A: 927-944.
  • 10LAI SL, GOLDSTEIN LJ, GOTTESMAN MM, et al. MDR1 gene expression in lung cancer[J]. J Natl Cancer Inst, 1989, 81(15):1144-1150.

共引文献18

同被引文献39

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部